Varicella zoster reactivation is a known risk following stem-cell transplantation, but has become more infrequent since universal antiviral prophylaxis. We report an unusual case of late, disseminated reactivation in a 27-year-old man with positive pre-transplant serology, and discuss implications for post-transplant prophylaxis and immune monitoring.
CITATION STYLE
Edwards, A. E., Suarez, C., & Lambourne, J. (2021). Lesson of the month: Late, disseminated herpes zoster reactivation in a stem cell transplant recipient: Implications for post-transplant prophylaxis and immune monitoring. Clinical Medicine, Journal of the Royal College of Physicians of London, 21(3), E309–E312. https://doi.org/10.7861/CLINMED.2021-0064
Mendeley helps you to discover research relevant for your work.